Non descent vaginal hysterectomy Surgery Non descent vaginal hysterectomy
Conditions
Interventions
Participants are randomised to one of two groups in a 1:1 ratio using computer generated block randomisation.
Intervention group: Participants are given ropivacaine at a total dose of 50 ml, 30 ml of
Sponsors
Benha University
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1. Female 2. 45 to 70 years old 3. Scheduled for NDVH for benign indications without need for oophorectomy or vaginal reconstructive surgery
Exclusion criteria
Exclusion criteria: 1. Patient weight less than 50 kg 2. Allergy to amide local anathetic 3. Dementia or mental retardation to a degree which would interfere with data collection 4. Contraindication to non descent vaginal hysterectomy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain is measured using the visual analogue score at 0.5, 1, 2, 4, 8, 12 and 24 hours post-operatively. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Time in hours to get out of bed after operation is measured by nurse responsible for the patient at 8 and 12 hours post-operatively 2. Hospital stay in days is measured by nurse at time of discharge of the patient 3. Total Narcotic dose (Nalbuphine) is measured by nurse at 1 and 24 hours post-operatively 4. Total parentral NSAID (diclofenac sodium) used in the first 24 hours after surgery is measured by nurse at 24 hours post-operatively 5. Number and proportion of patients with nausea and vomiting in the first 24 hours is measured by nurse at 24 hours post-operatively 6. Time spent in the post-anethesia care unit is measured by nurse at time of discharge from the post-anethesia care unit | — |
Countries
Egypt
Outcome results
None listed